A multicenter randomized study of adjuvant heat-shock protein peptide-complex 96 (HSPPC-96) vaccine in patients with high-risk of recurrence after nephrectomy for renal cell carcinoma (RCC)-a preliminary report.
2004
2618 Background: HSPPC-96 is an autologous, polyvalent vaccine produced from resected cancer tissue. This trial investigates the use of HSPPC-96 versus observation in patients with RCC at high-risk...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
13
Citations
NaN
KQI